A General Anesthesia Regimen for DBS Surgery in Patients With PD

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

February 27, 2025

Study Completion Date

March 5, 2025

Conditions
Parkinson's Disease (PD)
Interventions
DRUG

0.5~1ug/kg/min remifentanil combined with 0.2~0.5mg/kg/h esketamine for the physiological testing phase of DBS surgery.

Throughout the first and third stages of surgery, all patients receive a traditional induction of anesthesia. Fifteen minutes before the second stage of surgery (MER and clinical assessment), when the burr hole is ready, the propofol and sevoflurane infusion is discontinued, and patients receive 0.5\~1ug/kg/min remifentanil combined with 0.2\~0.5mg/kg/h esketamine. On completion of the second stage of surgery, the interventional drug is discontinued and propofol combined with sevoflurane is resumed until the end of the third stage.

Trial Locations (1)

200127

Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT06658132 - A General Anesthesia Regimen for DBS Surgery in Patients With PD | Biotech Hunter | Biotech Hunter